Finke Daniel P

Insider profile

Finke Daniel P's trades of CVS Health Corporation's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
392.90
Quantity 65,583 -38.6%
Value US$3,751,394
Transaction date
Planned sale
Price
57.73
Quantity 61,825 +31.2%
Value US$1,585,045
Transaction date
Planned sale
Price
415.74
Quantity 90,952 -7.0%
Value US$1,397,508
Transaction date
Planned sale
Price
100.13
Quantity 27,166 -35.1%
Value US$2,720,132
Transaction date
Planned sale
Price
100.13
Quantity 16,161 -24.4%
Value US$1,618,201
Transaction date
Planned sale
Price
86.60
Quantity 37,594 -61.7%
Value US$3,255,640
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-05 2022-08-03
PlS Planned sale
65,583 -38.6%
392.90
US$3,751,394 		65,583 -38.6% 392.90 US$3,751,394
2022-04-06 2022-04-05
PlS Planned sale
61,825 +31.2%
57.73
US$1,585,045 		61,825 +31.2% 57.73 US$1,585,045
2022-04-06 2022-04-04
PlS Planned sale
90,952 -7.0%
415.74
US$1,397,508 		90,952 -7.0% 415.74 US$1,397,508
2022-04-06 2022-04-04
PlS Planned sale
27,166 -35.1%
100.13
US$2,720,132 		27,166 -35.1% 100.13 US$2,720,132
2022-04-06 2022-04-04
PlS Planned sale
16,161 -24.4%
100.13
US$1,618,201 		16,161 -24.4% 100.13 US$1,618,201
2021-06-08 2021-06-07
PlS Planned sale
37,594 -61.7%
86.60
US$3,255,640 		37,594 -61.7% 86.60 US$3,255,640